García-Álvarez JL

Language: Spanish
References: 6
Page: 351-352
PDF size: 24.68 Kb.

Text Extraction

No Abstract

REFERENCES

1. Zambrano-Velarde MA, De la O-Peña D, Chávez-Peña Q, Bedolla-Barajas M. Rituximab en púrpura trombocitopénica inmune refractaria. Rev Med Inst Mex Seguro Soc 2012; 50(2):203-207.

2. Gómez-Almaguer D. Anticuerpos monoclonales en el tratamiento de enfermedades autoinmunes. Rev Hematol 2010;11(Supl 1):60-62.

3. García-Chávez J, Majluf-Cruz A, Montiel-Cervantes L, García- Ruiz Esparza M, Vela-Ojeda J; Mexican Hematology Study Group. Rituximab therapy for chronic and refractory immune thrombocytopenic purpura: a long-term follow-up analysis. Ann Hematol 2007;86(12):871-877. Disponible en http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2040174/

4. Monografía de rituximab. Diccionario de Especialidades Farmacéuticas. Quincuagésima séptima edición. México: PLM; 2011.

5. Klink DT, van Elburg RM, Schreurs MWJ, van Well GTJ. Rituximab administration in third trimester of pregnancy suppresses neonatal B-cell development. Clinical Developmental Immunology (Revista Online). Volume 2008. Article ID 271363, 6 pages. Doi:10.1155/2008/271363. Disponible en http://www.hindawi.com/journals/cdi/2008/ 271363/

6. Chambers C, Koren G, Tutuncu ZN, Johnson D, Jones KL. Are news agents used to treat rheumatoid arthritis safe to take during pregnancy? Can Fam Physician 2007; 53:409-412. Disponible en http://www.motherisk.org/prof/ updatesDetail.jsp?content_id=855